Benzodiazepines. 4. 2-Oxyamino-5-phenyl-3H-1,4-benzodiazepines.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001552:Benzazepines / Q000138:chemical synthesis* / Q000494:pharmacology; D002490:Central Nervous System / Q000187:drug effects; D003864:Depression, Chemical; D004357:Drug Synergism; D004597:Electroshock; D000431:Ethanol / Q000494:pharmacology; D006898:Hydroxylamines / Q000138:chemical synthesis / Q000494:pharmacology; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D010424:Pentobarbital / Q000494:pharmacology; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D012663:Semicarbazides / Q000037:antagonists & inhibitors; D013329:Structure-Activity Relationship; D013331:Strychnine / Q000037:antagonists & inhibitors; D013871:Thiones / Q000037:antagonists & inhibitors; D014149:Tranquilizing Agents / Q000138:chemical synthesis* / Q000494:pharmacology
D001552:Benzazepines; D006898:Hydroxylamines; D012663:Semicarbazides; D013871:Thiones; D014149:Tranquilizing Agents; D000431:Ethanol; D013331:Strychnine; D010424:Pentobarbital; D010433:Pentylenetetrazole